WebOct 26, 2024 · A Phase 2, Randomized, Double-Blind Study of Pembrolizumab (MK-3475) Plus Epacadostat (INCB024360) Versus Pembrolizumab Plus Placebo as First-Line Treatment in Patients With Metastatic Non-Small Cell Lung Cancer Expressing High Levels of PD-L1: Actual Study Start Date : December 15, 2024: Actual Primary Completion Date : … WebEpacadostat, also known as INCB024360 or INCB24360, is an orally available hydroxyamidine and inhibitor of indoleamine 2,3-dioxygenase (IDO1), with potential immunomodulating and antineoplastic activities. INCB024360 targets and binds to IDO1, an enzyme responsible for the oxidation of tryptophan into kynurenine. By inhibiting IDO1 and …
氢氯吡格雷片 - 百度百科
WebEpacadostat (INCB024360) analogue (INCB14943) is a potent, competitive IDO1 (indoleamine- (2,3)-dioxygenase) inhibitor with IC50 of 67 nM. In HeLa cells, INCB024360 shows higher inhibitory activity on IDO1 with IC50 of 19 nM. [1] In coculture systems of human allogeneic lymphocytes with dendritic cells or tumor cells, INCB024360, via IDO1 ... WebDec 17, 2014 · A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. finery waterloo iowa
奥氮平 - 维基百科,自由的百科全书
WebDec 5, 2024 · 目前小分子IDO1抑制剂的临床试验涉及Epacadostat(INCB024360)、Navoximod(GDC-0919)、BMS-986205和PF-06840003。 Epacadostat是临床研究进展较快的IDO1抑制剂,具有羟基脒和氨磺胺功能。Epacadostat是口服可逆的竞争性IDO1抑制剂,但在晚期癌症患者中单剂给药时未显示客观反应。 Webincb024360是一种强效的和选择性的ido1抑制剂,ic50值为10 nm [ 1 ]。ido是吲哚胺-吡咯2,3-双加氧酶。ido是由ido1 基因编码的酶。ido是色氨酸的限速酶和第一个酶,色氨酸是 … WebApr 29, 2010 · Here, we describe INCB024360, a novel IDO1 inhibitor, and investigate its roles in regulating various immune cells and therapeutic potential as an anticancer agent. … finery wifi smart switch